Menu

Agile Therapeutics, Inc. AGRX

Full chart Compare
Set alert

Price alert · AGRX

All alert types
1.51 0.00 (+0.00%)

Aug 22, 2024, 3:58 PM EDT

1.44 Day range 1.51

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $5.42MExpenses → Selling, General & Admin: $28.27MExpenses → Research & Development: $2.23MGross Profit → Expenses: $10.62MRevenue → Gross Profit: $10.62MRevenue → Cost of Revenue: $8.98MNet Loss → Expenses: $14.46MOther Income$5.42MGross Profit$10.62MNet Loss$14.46MCost of Revenue$8.98MExpenses$30.50MSelling, General & Admin$28.27MResearch & Development$2.23MRevenue$19.59M

Latest period ending Dec 31, 2023 · select a line to chart its full history

AGRX annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
19.59M10.88M4.10M749.00K0
10.62M4.05M-6.62M467.00K0
-19.88M-52.56M-71.00M-49.05M-18.86M
-14.46M-25.41M-71.07M-51.85M-18.61M
-6.71-58.79-1,464.20-1,220.00-760.00
AGRX annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
2.56M5.25M19.14M14.46M34.48M
10.26M14.24M39.33M73.06M49.54M
26.57M19.79M35.42M23.73M3.79M
1.81M1.89M17.62M16.38M0
-16.32M-5.54M3.92M49.33M45.74M
AGRX annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-9.58M-35.95M-65.20M-47.31M-15.69M
6.89M22.18M30.42M67.98M42.41M
-2.69M-13.90M4.68M-20.02M26.63M